Search clinical trials for: Non-vitamin K Oral Anticoagulants (NOACs)

Total 488699 results

Cui Yimin

Unknown

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Pharmacokinetics | Pharmacodynamics | Apixaban | Pharmacogenomics | Accurate Medication | Rivaroxaban | Novel Oral Anticoagulants | NOACs | Dabigatran

China
Peking University First Hospital

Not yet recruiting

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Bleeding | Pharmacodynamics | Apixaban | Pharmacogenomics | Biomarker | Ticagrelor | Rivaroxaban | Novel Oral Anticoagulants | NOACs | Dabigatran | Edoxaban | RNA Profile

China
University Hospital, Basel, Switzerland

Completed

New Oral Anticoagulants (NOAC) in Stroke Patients (NOACISPLongTer)

Stroke | Atrial Fibrillation

Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...
The Interuniversity Cardiology Institute of the Netherlands

Unknown

NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease (NOTE)

Atrial Fibrillation | Congenital Heart Defects | Ectopic Atrial Tachycardia

Netherlands
National Research Center for Preventive Medicine

Completed

Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY (ANTEY)

Atrial Fibrillation

Russian Federation
Henan Provincial People's Hospital

Recruiting

NOACs Use in AF or VTE (SUNSHINE Registry)

Atrial Fibrillation | Venous Thromboembolism | Oral Anticoagulant

China
Centre Hospitalier Universitaire de Besancon
Etablissement Français du Sang

Completed

Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events (Pgp NACO)

Hemorrhage | Thromboembolism | Anticoagulants

France
Brigham and Women's Hospital

Completed

Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology (IQ-MATCH)

Atrial Fibrillation
Tokai University
Daiichi Sankyo, Inc.

Unknown

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) (CMB-NOW)

Ischemic Stroke | Atrial Fibrillation Symptomatic

Japan
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (ALTERNATIVE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders

United States
Malmö University
Odontologisk Forskning i Region Skåne (OFRS)

Completed

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Postoperative Complications | Hemorrhage | Anticoagulant-induced Bleeding | Oral Surgical Procedures | Anticoagulants Causing Adverse Effects in Therapeutic Use | Surgery, Oral

Sweden
Steward St. Elizabeth's Medical Center of Boston...

Completed

Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs

Atrial Fibrillation

United States
China National Center for Cardiovascular Diseases

Not yet recruiting

LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

Non-paroxysmal Atrial Fibrillation

China
Hospital do Coracao

Completed

RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial

Valvular Heart Disease

Brazil
Mahidol University

Completed

Efficacy and Safety of Oral Anticoagulants Among Thai Octogenarians With Nonvalvular Atrial Fibrillation

Stroke | Atrial Fibrillation

Thailand
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

COVID-19 and Venous Thromboembolism Risk

Covid19 | Venous Thromboembolism

United States
HK inno.N Corporation

Completed

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Healthy

Korea, Republic of
Scientific Institute San Raffaele

Unknown

Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI) (TRIDUAL-PCI)

Myocardial Infarction | Coronary Disease | Atrial Fibrillation | Anticoagulant-induced Bleeding

Italy
Bayer
Janssen Research & Development, LLC

Completed

Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases (TREND)

Atrial Fibrillation

Colombia
Population Health Research Institute

Completed

NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH (NASPAF-ICH)

Atrial Fibrillation | Intracerebral Hemorrhage

Canada
Boehringer Ingelheim

Completed

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Atrial Fibrillation

Spain
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Daiichi Sankyo, Inc.

Completed

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

Atrial Fibrillation

Turkey
Boehringer Ingelheim

Completed

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain (RE-CONOCE)

Atrial Fibrillation

Spain
University Hospital Heidelberg

Unknown

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation (HERA-FIB)

Atrial Fibrillation

Germany
St. Paul's Hospital, Canada

Active, not recruiting

The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

Atrial Fibrillation

Canada
Bayer
Janssen Research & Development, LLC

Completed

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon (ReLoaDeD)

Atrial Fibrillation

Germany
Sheba Medical Center

Unknown

Therapy With New Oral Anticoagulants

Atrial Fibrillation | Non-valvular Atrial Fibrillation

Israel
Bayer

Completed

Anticoagulation Preference by AF Patients Study (PRiSMA-AF)

Atrial Fibrillation

Switzerland
Bayer
Janssen Research & Development, LLC

Terminated

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients. (PROTECT-AF)

Non-valvular Atrial Fibrillation

Norway
China National Center for Cardiovascular Diseases

Recruiting

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

Ventricular Thrombus

China
AtriCure, Inc.

Completed

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS) (ATLAS)

Post-Operative Atrial Fibrillation

United States
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Treatment of Venous Thromboembolism in Cancer Patients

Sweden
Korea University Anam Hospital

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation (REVISE-AF)

Atrial Fibrillation | Anticoagulant Adverse Reaction

Korea, Republic of
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery (ASPIRE-AF)

Stroke | Atrial Fibrillation

Canada, Australia, Germany, Denmark, Switzerland, Spain, Korea, Republic of, New Zealand, India, Netherlands, Argentina, United Kingdom, Brazil, Italy, Nepal, Sweden, Pakistan
Herlev and Gentofte Hospital
Danish Society of Cardiology

Recruiting

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) (DANNOAC-VTE)

Deep Vein Thrombosis | Pulmonary Embolism

Denmark
Herlev and Gentofte Hospital
Danish Society of Cardiology

Recruiting

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation (DANNOAC-AF)

Atrial Fibrillation | Atrial Flutter

Denmark
Atrial Fibrillation Network
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Deutsches Zentrum für...

Terminated

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes (NOAH)

Atrial High Rate Episodes

Austria, Belgium, Bulgaria, Czechia, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, Ukraine, United Kingdom, Denmark
Attikon Hospital
Hellenic Cardiology Society

Completed

The Greek AntiPlatElet Atrial Fibrillation Registry. (GRAPE-AF)

Coronary Artery Disease | Atrial Fibrillation

Greece
Bayer

Completed

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care (BEST-AF)

Atrial Fibrillation

United Kingdom
Medical University of Warsaw

Unknown

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT) (CRAFT)

Atrial Fibrillation

Poland
Helsinki University Central Hospital
University of Turku

Completed

Non-vitamin K Oral Anticoagulants in Cardioversion (FinCV3)

Atrial Fibrillation
Hospital Sirio-Libanes
Daiichi Sankyo

Not yet recruiting

Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE (VISIONAIRE) (VISIONAIRE)

Chronic Kidney Diseases | Atrium; Fibrillation
Brazilian Clinical Research Institute
Alliança Diagnostic

Not yet recruiting

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke (ARCHIMEDES)

Ischemic Stroke
Mahidol University
Health Systems Research Institute; The Heart Association of Thailand

Not yet recruiting

COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

Atrial Fibrillation

Thailand
University of Alabama at Birmingham
University Teaching Hospital, Lusaka, Zambia; Cameroon Baptist Convention Health and other collaborators

Not yet recruiting

Intrapartum Sildenafil in Laboring Mothers (PRISM)

Development, Infant | Neonatal Asphyxia | Intrapartum Fetal Distress | Intrapartum Asphyxia

Zambia, Cameroon, Kenya
VarmX B.V.

Recruiting

Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant

Coagulation Disorder

Netherlands
Peking Union Medical College Hospital
Xiangya Hospital of Central South University; Ruijin Hospital; China-Japan Friendship...

Recruiting

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Pulmonary Embolism

China
Peking University Third Hospital

Recruiting

Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults

Health

China
Children's Mercy Hospital Kansas City
Indiana Clinical and Translational Sciences Institute

Recruiting

IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease (IMPROVE-FALD)

Fontan Circulation

United States
Walton Centre NHS Foundation Trust
University of Liverpool; National Institute for Health Research, United Kingdom

Not yet recruiting

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)

Traumatic Intracranial Haemorrhage

Search clinical trials for: Non-vitamin K Oral Anticoagulants (NOACs)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations